| |
| |
|
| Insider
Information: |
Remeditex Ventures Llc |
| Relationship: |
10% Owner |
| City: |
Dallas |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
5,878,658 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$13,846,270 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,878,658 |
|
|
| Total
Value |
$13,846,270 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
2014-12-23 |
1,807,603 |
2014-12-23 |
0 |
Premium* |
|
|
Apollo Endosurgery, Inc |
APEN |
10% Owner |
2019-12-29 |
1,309,392 |
2019-12-29 |
0 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
10% Owner |
2018-01-29 |
2,761,663 |
2018-01-25 |
0 |
Premium* |
|
|
Soliton Inc |
SOLY |
10% Owner |
2021-12-16 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SOLY |
Soliton Inc |
10% Owner |
– – • |
2021-12-16 |
4 |
D |
$22.60 |
$208,242,660 |
D/D |
(9,214,277) |
0 |
0 |
- |
|
| SOLY |
Soliton Inc |
10% Owner |
– – • |
2020-06-30 |
4 |
B |
$8.30 |
$999,992 |
D/D |
120,481 |
9,214,277 |
2.45 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2019-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,309,392 |
1,309,392 |
0 |
- |
|
| SOLY |
Soliton Inc |
10% Owner |
• • • |
2019-10-11 |
4 |
B |
$0.00 |
$0 |
D/D |
155,280 |
9,093,796 |
2.37 |
- |
|
| SOLY |
Soliton Inc |
10% Owner |
• • • |
2019-06-19 |
4 |
B |
$0.00 |
$0 |
D/D |
357,143 |
8,938,516 |
2.37 |
- |
|
| SOLY |
Soliton Inc |
10% Owner |
– – • |
2019-02-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,581,373 |
|
- |
|
| VYNE |
VYNE Therapeutics Inc |
10% Owner |
– – • |
2018-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,178,809 |
2,761,663 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
10% Owner |
– – • |
2018-01-25 |
4 |
B |
$17.00 |
$1,700,000 |
D/D |
100,000 |
1,582,854 |
2.45 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
10% Owner |
– – • |
2014-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
43,563 |
1,807,603 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
10% Owner |
– – • |
2014-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,764,040 |
1,764,040 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
